Part 10 – Standing Rules: Funding of therapies for Multiple Sclerosis


Regulation 56 – Scheme for the funding of certain disease modifying therapies for Multiples Sclerosis (1) A relevant body must, in exercising its functions under or by virtue of section 3(1), 3A(1) or 3B of the 2006 Act, ensure that- (a) a scheme product is supplied or administered in accordance with the scheme to a […]

You need to be a logged-in Community Care Inform subscriber to view this article

If you have an Inform subscription, log in here

If you having difficulties logging in, please contact our helpdesk

Find out more about how to subscribe to Inform